发现并描述 1H-吡唑-5-基-2-苯基乙酰胺作为新型非脲基含有的 GIRK1/2 钾通道激活剂。
Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators.
机构信息
Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University , Nashville, Tennessee 37232, United States.
Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center , Omaha, Nebraska 68198, United States.
出版信息
ACS Chem Neurosci. 2017 Sep 20;8(9):1873-1879. doi: 10.1021/acschemneuro.7b00217. Epub 2017 Jul 19.
Abstract
The G protein-gated inwardly-rectifying potassium channels (GIRK, K3) are a family of inward-rectifying potassium channels, and there is significant evidence supporting the roles of GIRKs in a number of physiological processes and as potential targets for numerous indications. Previously reported urea containing molecules as GIRK1/2 preferring activators have had significant pharmacokinetic (PK) liabilities. Here we report a novel series of 1H-pyrazolo-5-yl-2-phenylacetamides in an effort to improve upon the PK properties. This series of compounds display nanomolar potency as GIRK1/2 activators with improved brain distribution (rodent K > 0.6).
摘要
G 蛋白门控内向整流钾通道（GIRK，K3）是内向整流钾通道家族的一员，有大量证据表明它们在许多生理过程中发挥作用，并可能成为许多适应症的潜在靶点。以前报道的含脲分子作为 GIRK1/2 的优先激活剂具有显著的药代动力学（PK）缺陷。在这里，我们报告了一系列新型的 1H-吡唑并-5-基-2-苯基乙酰胺，旨在改善 PK 性质。该系列化合物作为 GIRK1/2 激活剂具有纳摩尔效力，并且改善了脑分布（啮齿动物 K > 0.6）。
相似文献
1
Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators.发现并描述 1H-吡唑-5-基-2-苯基乙酰胺作为新型非脲基含有的 GIRK1/2 钾通道激活剂。
ACS Chem Neurosci. 2017 Sep 20;8(9):1873-1879. doi: 10.1021/acschemneuro.7b00217. Epub 2017 Jul 19.
2
Discovery, synthesis and characterization of a series of (1-alkyl-3-methyl-1H-pyrazol-5-yl)-2-(5-aryl-2H-tetrazol-2-yl)acetamides as novel GIRK1/2 potassium channel activators.发现、合成及表征一系列（1-烷基-3-甲基-1H-吡唑-5-基）-2-（5-芳基-2H-四唑-2-基）乙酰胺作为新型 GIRK1/2 钾通道激活剂。
Bioorg Med Chem Lett. 2019 Mar 15;29(6):791-796. doi: 10.1016/j.bmcl.2019.01.027. Epub 2019 Jan 23.
3
Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels.发现并表征 VU0529331，一种同型 G 蛋白门控内向整流钾 (GIRK) 通道的合成小分子激活剂。
ACS Chem Neurosci. 2019 Jan 16;10(1):358-370. doi: 10.1021/acschemneuro.8b00287. Epub 2018 Sep 13.
4
Discovery of potent and selective GIRK1/2 modulators via 'molecular switches' within a series of 1-(3-cyclopropyl-1-phenyl-1H-pyrazol-5-yl)ureas.通过一系列1-(3-环丙基-1-苯基-1H-吡唑-5-基)脲中的“分子开关”发现强效和选择性GIRK1/2调节剂。
Bioorg Med Chem Lett. 2014 Nov 1;24(21):5102-6. doi: 10.1016/j.bmcl.2014.08.061. Epub 2014 Sep 16.
5
The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents.小分子 GAT1508 激活大脑特异性 GIRK1/2 通道异源二聚体，并促进啮齿动物条件性恐惧的消退。
J Biol Chem. 2020 Mar 13;295(11):3614-3634. doi: 10.1074/jbc.RA119.011527. Epub 2020 Jan 17.
6
Discovery and SAR of a novel series of GIRK1/2 and GIRK1/4 activators.发现并研究了一系列新型 GIRK1/2 和 GIRK1/4 激活剂。
Bioorg Med Chem Lett. 2013 Sep 15;23(18):5195-8. doi: 10.1016/j.bmcl.2013.07.002. Epub 2013 Jul 18.
7
Discovery, synthesis and biological characterization of a series of -(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators.一系列新型GIRK1/2钾通道激活剂——α-(1-(1,1-二氧代四氢噻吩-3-基)-3-甲基-1-吡唑-5-基)乙酰胺醚的发现、合成及生物学特性研究
RSC Med Chem. 2021 Jun 21;12(8):1366-1373. doi: 10.1039/d1md00129a. eCollection 2021 Aug 18.
8
GIRK1-mediated inwardly rectifying potassium current suppresses the epileptiform burst activities and the potential antiepileptic effect of ML297.GIRK1 介导的内向整流钾电流抑制癫痫样爆发活动和 ML297 的潜在抗癫痫作用。
Biomed Pharmacother. 2018 May;101:362-370. doi: 10.1016/j.biopha.2018.02.114. Epub 2018 Mar 22.
9
ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice.ML297（VU0456810）是一种强效且选择性的 GIRK 钾通道激活剂，在小鼠中显示出抗癫痫特性。
ACS Chem Neurosci. 2013 Sep 18;4(9):1278-86. doi: 10.1021/cn400062a. Epub 2013 Jun 13.
10
Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297.新型抗焦虑药物 ML297 激活 G 蛋白门控内向整流钾 (GIRK) 通道的机制。
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10755-60. doi: 10.1073/pnas.1405190111. Epub 2014 Jul 7.
引用本文的文献
1
Further Structure-Activity Relationship of G Protein-Gated Inwardly Rectifying Potassium Channels 1/2 Activators: Synthesis and Biological Characterization of In Vitro Tool Compounds.G蛋白门控内向整流钾通道1/2激活剂的进一步构效关系：体外工具化合物的合成与生物学特性
ChemMedChem. 2025 Jul 1;20(13):e202500037. doi: 10.1002/cmdc.202500037. Epub 2025 May 9.
2
A muscarinic, GIRK channel-mediated inhibition of inspiratory-related XII nerve motor output emerges in early postnatal development in mice.在出生后早期发育过程中，小鼠的吸气相关 XII 神经运动输出会出现一种毒蕈碱型 GIRK 通道介导的抑制。
J Appl Physiol (1985). 2023 Nov 1;135(5):1041-1052. doi: 10.1152/japplphysiol.00042.2023. Epub 2023 Sep 28.
3
Use of a Molecular Switch Probe to Activate or Inhibit GIRK1 Heteromers In Silico Reveals a Novel Gating Mechanism.使用分子开关探针在计算机上激活或抑制 GIRK1 异源二聚体揭示了一种新的门控机制。
Int J Mol Sci. 2022 Sep 16;23(18):10820. doi: 10.3390/ijms231810820.
4
Neuronal G protein-gated K channels.神经元 G 蛋白门控钾通道。
Am J Physiol Cell Physiol. 2022 Aug 1;323(2):C439-C460. doi: 10.1152/ajpcell.00102.2022. Epub 2022 Jun 15.
5
A novel small-molecule selective activator of homomeric GIRK4 channels.一种同型 GIRK4 通道的新型小分子选择性激活剂。
J Biol Chem. 2022 Jun;298(6):102009. doi: 10.1016/j.jbc.2022.102009. Epub 2022 May 4.
6
Discovery, synthesis and biological characterization of a series of -(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators.一系列新型GIRK1/2钾通道激活剂——α-(1-(1,1-二氧代四氢噻吩-3-基)-3-甲基-1-吡唑-5-基)乙酰胺醚的发现、合成及生物学特性研究
RSC Med Chem. 2021 Jun 21;12(8):1366-1373. doi: 10.1039/d1md00129a. eCollection 2021 Aug 18.
7
Next-generation inward rectifier potassium channel modulators: discovery and molecular pharmacology.下一代内向整流钾通道调节剂：发现与分子药理学。
Am J Physiol Cell Physiol. 2021 Jun 1;320(6):C1125-C1140. doi: 10.1152/ajpcell.00548.2020. Epub 2021 Apr 7.
8
Advances in Targeting GIRK Channels in Disease.疾病中靶向 GIRK 通道的研究进展。
Trends Pharmacol Sci. 2021 Mar;42(3):203-215. doi: 10.1016/j.tips.2020.12.002. Epub 2021 Jan 16.
9
Pyrazolyl-Ureas as Interesting Scaffold in Medicinal Chemistry.吡唑基-脲作为药物化学中的有趣骨架
Molecules. 2020 Jul 29;25(15):3457. doi: 10.3390/molecules25153457.
10
The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodents.小分子 GAT1508 激活大脑特异性 GIRK1/2 通道异源二聚体，并促进啮齿动物条件性恐惧的消退。
J Biol Chem. 2020 Mar 13;295(11):3614-3634. doi: 10.1074/jbc.RA119.011527. Epub 2020 Jan 17.
本文引用的文献
1
Multicomponent Dipolar Cycloaddition Strategy: Combinatorial Synthesis of Novel Spiro-Tethered Pyrazolo[3,4-b]quinoline Hybrid Heterocycles.多组分偶极环加成策略：新型螺连接吡唑并[3,4 - b]喹啉杂环的组合合成
ACS Comb Sci. 2016 May 9;18(5):262-70. doi: 10.1021/acscombsci.6b00003. Epub 2016 Apr 8.
2
Use of a novel rapid and resource-efficient cassette dosing approach to determine the pharmacokinetics and CNS distribution of small molecule 7-transmembrane receptor allosteric modulators in rat.采用新型快速且资源高效的盒式剂量测定方法，研究小分子 7 跨膜受体变构调节剂在大鼠中的药代动力学和中枢神经系统分布。
Pharmacol Res Perspect. 2014 Dec;2(6):e00077. doi: 10.1002/prp2.77. Epub 2014 Sep 1.
3
Discovery of potent and selective GIRK1/2 modulators via 'molecular switches' within a series of 1-(3-cyclopropyl-1-phenyl-1H-pyrazol-5-yl)ureas.通过一系列1-(3-环丙基-1-苯基-1H-吡唑-5-基)脲中的“分子开关”发现强效和选择性GIRK1/2调节剂。
Bioorg Med Chem Lett. 2014 Nov 1;24(21):5102-6. doi: 10.1016/j.bmcl.2014.08.061. Epub 2014 Sep 16.
4
Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297.新型抗焦虑药物 ML297 激活 G 蛋白门控内向整流钾 (GIRK) 通道的机制。
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10755-60. doi: 10.1073/pnas.1405190111. Epub 2014 Jul 7.
5
Strategic use of plasma and microsome binding to exploit in vitro clearance in early drug discovery.在早期药物发现中，利用血浆和微粒体结合的策略来开发体外清除率。
ACS Med Chem Lett. 2010 Feb 3;1(2):50-3. doi: 10.1021/ml900012h. eCollection 2010 May 13.
6
New insights into the therapeutic potential of Girk channels.Girk 通道治疗潜力的新见解。
Trends Neurosci. 2014 Jan;37(1):20-9. doi: 10.1016/j.tins.2013.10.006. Epub 2013 Nov 21.
7
Discovery and SAR of a novel series of GIRK1/2 and GIRK1/4 activators.发现并研究了一系列新型 GIRK1/2 和 GIRK1/4 激活剂。
Bioorg Med Chem Lett. 2013 Sep 15;23(18):5195-8. doi: 10.1016/j.bmcl.2013.07.002. Epub 2013 Jul 18.
8
Discovery of 'molecular switches' within a GIRK activator scaffold that afford selective GIRK inhibitors.发现 GIRK 激活剂支架内的“分子开关”，可提供选择性 GIRK 抑制剂。
Bioorg Med Chem Lett. 2013 Aug 15;23(16):4562-6. doi: 10.1016/j.bmcl.2013.06.023. Epub 2013 Jun 20.
9
ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice.ML297（VU0456810）是一种强效且选择性的 GIRK 钾通道激活剂，在小鼠中显示出抗癫痫特性。
ACS Chem Neurosci. 2013 Sep 18;4(9):1278-86. doi: 10.1021/cn400062a. Epub 2013 Jun 13.
10
G-protein-gated inwardly rectifying K+ channel 4 (GIRK4) immunoreactivity in chemically defined neurons of the hypothalamic arcuate nucleus that control body weight.G 蛋白门控内向整流钾通道 4（GIRK4）在控制体重的下丘脑弓状核的化学定义神经元中的免疫反应性。
J Chem Neuroanat. 2012 May;44(1):14-23. doi: 10.1016/j.jchemneu.2012.03.003. Epub 2012 Mar 23.
Zotero 插件